Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement (Q84019269)
Jump to navigation
Jump to search
scientific article published on 07 April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement |
scientific article published on 07 April 2010 |
Statements
Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement (English)
Hartmut Goldschmidt
Tilmann Bochtler
Arnt V Kristen
Ute Hegenbart
Ernst Hund
Axel Benner
Jörg Beimler
Markus Zorn